Dorothee C. Dartsch

ORCID: 0009-0000-3666-0121
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Medication Adherence and Compliance
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer therapeutics and mechanisms
  • Health Policy Implementation Science
  • Pharmaceutical studies and practices
  • DNA Repair Mechanisms
  • Cancer-related Molecular Pathways
  • Neutropenia and Cancer Infections
  • Education Methods and Technologies
  • Pharmaceutical Economics and Policy
  • Cell death mechanisms and regulation
  • Chronic Disease Management Strategies
  • Healthcare Technology and Patient Monitoring
  • Evaluation and Performance Assessment
  • Psoriasis: Treatment and Pathogenesis
  • Colorectal Cancer Treatments and Studies
  • Carcinogens and Genotoxicity Assessment
  • Chemotherapy-induced organ toxicity mitigation
  • Economic and Financial Impacts of Cancer
  • Retinoids in leukemia and cellular processes
  • Health Literacy and Information Accessibility
  • Mast cells and histamine
  • Patient Safety and Medication Errors
  • Safe Handling of Antineoplastic Drugs

University Hospital of Bern
2022

University Clinic of Pulmonary and Allergic Diseases Golnik
2022

University of Ljubljana
2022

University of Oslo
2022

KU Leuven
2022

Universität Hamburg
1999-2012

MSH Medical School Hamburg – University of Applied Sciences and Medical University
1999-2002

Fraunhofer Society
1999-2001

Patient adherence is necessary for successful medication therapy. However, highly complex regimens may lead to poor adherence, which decreases the effectiveness of treatment and often results in failure, excessive morbidity mortality, higher costs. To examine whether patient can be increased indirectly through reducing complexity by (a) pharmaceutical counseling hospital medical staff (b) additional information discharge letter primary care provider (PCP) about simplified medication. At...

10.18553/jmcp.2013.19.5.396 article EN Journal of Managed Care Pharmacy 2013-06-01

Several factors contribute to the complexity of pharmacotherapeutic regimens, like total number medications be taken, dosage units take at a time, frequency, as well specific directions concerning administration. The Medication Regimen Complexity Index (MRCI) is validated instrument developed in English for measurement given regimen.Translation MRCI into German and evaluation translated (MRCI-D) order make it more easily accessible use practice research.The process validation included...

10.1111/j.1365-2753.2011.01636.x article EN Journal of Evaluation in Clinical Practice 2011-02-14

The potential role of arachidonic acid metabolism in the enhancement (promotion) malignant transformation C3H/M2 mouse fibroblasts by tumor promoter 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was investigated using inhibitors cyclooxygenase and lipoxygenase activities. promoting effects TCDD (1.5 pM) reference 12-O-tetradecanoylphorbol-13-acetate (TPA; 0.4 mM) on carcinogen (N-methyl-N′-nitro-N-nitrosoguanidine or 3-methylcholanthrene)-pre-treated abolished cotreatment with indomethacin,...

10.1093/carcin/21.1.15 article EN Carcinogenesis 2000-01-01

Since 2022, patients with five or more medicines are eligible for a medication review (MR) in community pharmacy remunerated by the German health system. However, implementation has been slow, few pharmacies providing MRs. Stakeholders' input is necessary to detail how strategies can be executed effectively on national level. Prior research identified "external facilitation" and "altering incentives" as crucial achieve outcomes.

10.1007/s11096-024-01708-y article EN cc-by International Journal of Clinical Pharmacy 2024-03-15

<h3>Background</h3> Complex medication regimens may cause non-adherence. It is not known to which extent can be simplified by using combination and sustained release drugs whether such simplifications ‘survive’ in the outpatient setting. <h3>Purpose</h3> To investigate development of complexity at border between ambulatory hospital care benefit a pharmacist9s intervention minimise complexity. <h3>Materials methods</h3> In prospective study medications 240 patients was analysed times...

10.1136/ejhpharm-2012-000074.359 article EN European Journal of Hospital Pharmacy 2012-03-12

Was die Welt nicht braucht, sind zusatzliche Herausforderungen fur berufsbegleitende Fort- und Weiterbildung. Und damit ist das Thema “moderierte online-Seminare” auch schon vom Tisch. Konnte man meinen. Zeitliche ortliche Flexibilitat allein helfen keinem Teilnehmenden, wenn der Preis dafur gravierende Einbusen sind, z. B. auf Seiten Motivation, fachlichen organisatorischen Betreuung, Anwendungsubung des Transfers. [Die Autoren] zeigen in dieser Langfassung Vortrags 01.06.2012 -...

10.25656/01:8900 article DE 2013-01-01
Coming Soon ...